Literature DB >> 26130896

Anaplastic large-cell lymphoma in AIDS.

Michael L Krol1, Varsha Podduturi1, Abdulla Majid-Moosa1, John R Krause1, Adan Mora1.   

Abstract

AIDS-related malignancies may alter clinical courses and result in death in critically ill patients. We present a case of a newly diagnosed AIDS patient with Pneumocystis jiroveci pneumonia, Epstein-Barr virus, and cytomegalovirus infections who was found to have widely metastatic kinase-negative anaplastic large-cell lymphoma. This case demonstrates the diversity in the malignant presentation of HIV-infected patients, outside of the more commonly observed non-Hodgkin lymphomas.

Entities:  

Year:  2015        PMID： 26130896      PMCID： PMC4462229          DOI： 10.1080/08998280.2015.11929282

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  9 in total

1.  Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.

Authors:  Anas Younes; Nancy L Bartlett; John P Leonard; Dana A Kennedy; Carmel M Lynch; Eric L Sievers; Andres Forero-Torres
Journal:  N Engl J Med       Date:  2010-11-04       Impact factor: 91.245

2.  Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project.

Authors:  J R Anderson; J O Armitage; D D Weisenburger
Journal:  Ann Oncol       Date:  1998-07       Impact factor: 32.976

Review 3.  Human Immunodeficiency Virus-associated anaplastic large cell lymphoma.

Authors:  Kimberly Perez; Jorge Castillo; Bruce J Dezube; Liron Pantanowitz
Journal:  Leuk Lymphoma       Date:  2010-03

4.  Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification.

Authors:  S Ascani; P L Zinzani; F Gherlinzoni; E Sabattini; A Briskomatis; A de Vivo; M Piccioli; G Fraternali Orcioni; F Pieri; A Goldoni; P P Piccaluga; D Zallocco; R Burnelli; L Leoncini; B Falini; S Tura; S A Pileri
Journal:  Ann Oncol       Date:  1997-06       Impact factor: 32.976

5.  ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Authors:  Kerry J Savage; Nancy Lee Harris; Julie M Vose; Fred Ullrich; Elaine S Jaffe; Joseph M Connors; Lisa Rimsza; Stefano A Pileri; Mukesh Chhanabhai; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger
Journal:  Blood       Date:  2008-04-02       Impact factor: 22.113

6.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

7.  Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

Authors:  Pragna Patel; Debra L Hanson; Patrick S Sullivan; Richard M Novak; Anne C Moorman; Tony C Tong; Scott D Holmberg; John T Brooks
Journal:  Ann Intern Med       Date:  2008-05-20       Impact factor: 25.391

8.  A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.

Authors:  Andres Forero-Torres; John P Leonard; Anas Younes; Joseph D Rosenblatt; Pauline Brice; Nancy L Bartlett; Andre Bosly; Lauren Pinter-Brown; Dana Kennedy; Eric L Sievers; Ajay K Gopal
Journal:  Br J Haematol       Date:  2009-05-19       Impact factor: 6.998

9.  Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.

Authors:  Peter Reimer; Thomas Rüdiger; Eva Geissinger; Florian Weissinger; Christoph Nerl; Norbert Schmitz; Andreas Engert; Hermann Einsele; Hans Konrad Müller-Hermelink; Martin Wilhelm
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.